Report Detail
Global (United States, European Union and China) RNA Drugs Market Research Report 2019-2025
- RnM3446337 |
- 16 July, 2020 |
- Global |
- 150 Pages |
- QYResearch |
- Pharma & Healthcare
RNA Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global RNA Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the RNA Drugs market is segmented into
siRNA
ASO
miRNA
Nucleic Acid Aptamers
Segment by Application, the RNA Drugs market is segmented into
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Regional and Country-level Analysis
The RNA Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the RNA Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and RNA Drugs Market Share Analysis
RNA Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in RNA Drugs business, the date to enter into the RNA Drugs market, RNA Drugs product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
1 Study Coverage
- 1.1 RNA Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key RNA Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global RNA Drugs Market Size Growth Rate by Type
- 1.4.2 siRNA
- 1.4.3 ASO
- 1.4.4 miRNA
- 1.4.5 Nucleic Acid Aptamers
- 1.5 Market by Application
- 1.5.1 Global RNA Drugs Market Size Growth Rate by Application
- 1.5.2 Cancer
- 1.5.3 Diabetes
- 1.5.4 Tuberculosis
- 1.5.5 Cardiovascular Diseases
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global RNA Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global RNA Drugs Revenue 2015-2026
- 2.1.2 Global RNA Drugs Sales 2015-2026
- 2.2 Global RNA Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global RNA Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global RNA Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global RNA Drugs Competitor Landscape by Players
- 3.1 RNA Drugs Sales by Manufacturers
- 3.1.1 RNA Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 RNA Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 RNA Drugs Revenue by Manufacturers
- 3.2.1 RNA Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 RNA Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global RNA Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by RNA Drugs Revenue in 2019
- 3.2.5 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 RNA Drugs Price by Manufacturers
- 3.4 RNA Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 RNA Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers RNA Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into RNA Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global RNA Drugs Market Size by Type (2015-2020)
- 4.1.1 Global RNA Drugs Sales by Type (2015-2020)
- 4.1.2 Global RNA Drugs Revenue by Type (2015-2020)
- 4.1.3 RNA Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global RNA Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global RNA Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global RNA Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 RNA Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global RNA Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global RNA Drugs Market Size by Application (2015-2020)
- 5.1.1 Global RNA Drugs Sales by Application (2015-2020)
- 5.1.2 Global RNA Drugs Revenue by Application (2015-2020)
- 5.1.3 RNA Drugs Price by Application (2015-2020)
- 5.2 RNA Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global RNA Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global RNA Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global RNA Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America RNA Drugs by Country
- 6.1.1 North America RNA Drugs Sales by Country
- 6.1.2 North America RNA Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America RNA Drugs Market Facts & Figures by Type
- 6.3 North America RNA Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe RNA Drugs by Country
- 7.1.1 Europe RNA Drugs Sales by Country
- 7.1.2 Europe RNA Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe RNA Drugs Market Facts & Figures by Type
- 7.3 Europe RNA Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific RNA Drugs by Region
- 8.1.1 Asia Pacific RNA Drugs Sales by Region
- 8.1.2 Asia Pacific RNA Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific RNA Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific RNA Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America RNA Drugs by Country
- 9.1.1 Latin America RNA Drugs Sales by Country
- 9.1.2 Latin America RNA Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America RNA Drugs Market Facts & Figures by Type
- 9.3 Central & South America RNA Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa RNA Drugs by Country
- 10.1.1 Middle East and Africa RNA Drugs Sales by Country
- 10.1.2 Middle East and Africa RNA Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa RNA Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa RNA Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description and Business Overview
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer RNA Drugs Products Offered
- 11.1.5 Pfizer Related Developments
- 11.2 Roche
- 11.2.1 Roche Corporation Information
- 11.2.2 Roche Description and Business Overview
- 11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Roche RNA Drugs Products Offered
- 11.2.5 Roche Related Developments
- 11.3 Sanofi-Aventis
- 11.3.1 Sanofi-Aventis Corporation Information
- 11.3.2 Sanofi-Aventis Description and Business Overview
- 11.3.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Sanofi-Aventis RNA Drugs Products Offered
- 11.3.5 Sanofi-Aventis Related Developments
- 11.4 Abbott Laboratories
- 11.4.1 Abbott Laboratories Corporation Information
- 11.4.2 Abbott Laboratories Description and Business Overview
- 11.4.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Abbott Laboratories RNA Drugs Products Offered
- 11.4.5 Abbott Laboratories Related Developments
- 11.5 Arrowhead Pharmaceuticals
- 11.5.1 Arrowhead Pharmaceuticals Corporation Information
- 11.5.2 Arrowhead Pharmaceuticals Description and Business Overview
- 11.5.3 Arrowhead Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Arrowhead Pharmaceuticals RNA Drugs Products Offered
- 11.5.5 Arrowhead Pharmaceuticals Related Developments
- 11.6 Benitec Biopharma
- 11.6.1 Benitec Biopharma Corporation Information
- 11.6.2 Benitec Biopharma Description and Business Overview
- 11.6.3 Benitec Biopharma Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Benitec Biopharma RNA Drugs Products Offered
- 11.6.5 Benitec Biopharma Related Developments
- 11.7 Calimmune Inc
- 11.7.1 Calimmune Inc Corporation Information
- 11.7.2 Calimmune Inc Description and Business Overview
- 11.7.3 Calimmune Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Calimmune Inc RNA Drugs Products Offered
- 11.7.5 Calimmune Inc Related Developments
- 11.8 Dicerna
- 11.8.1 Dicerna Corporation Information
- 11.8.2 Dicerna Description and Business Overview
- 11.8.3 Dicerna Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Dicerna RNA Drugs Products Offered
- 11.8.5 Dicerna Related Developments
- 11.9 Gradalis
- 11.9.1 Gradalis Corporation Information
- 11.9.2 Gradalis Description and Business Overview
- 11.9.3 Gradalis Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Gradalis RNA Drugs Products Offered
- 11.9.5 Gradalis Related Developments
- 11.10 Quark
- 11.10.1 Quark Corporation Information
- 11.10.2 Quark Description and Business Overview
- 11.10.3 Quark Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Quark RNA Drugs Products Offered
- 11.10.5 Quark Related Developments
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description and Business Overview
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer RNA Drugs Products Offered
- 11.1.5 Pfizer Related Developments
- 11.12 Senesco
- 11.12.1 Senesco Corporation Information
- 11.12.2 Senesco Description and Business Overview
- 11.12.3 Senesco Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Senesco Products Offered
- 11.12.5 Senesco Related Developments
- 11.13 Silence Therapeutics
- 11.13.1 Silence Therapeutics Corporation Information
- 11.13.2 Silence Therapeutics Description and Business Overview
- 11.13.3 Silence Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Silence Therapeutics Products Offered
- 11.13.5 Silence Therapeutics Related Developments
- 11.14 Silenseed
- 11.14.1 Silenseed Corporation Information
- 11.14.2 Silenseed Description and Business Overview
- 11.14.3 Silenseed Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Silenseed Products Offered
- 11.14.5 Silenseed Related Developments
- 11.15 Tekmira
- 11.15.1 Tekmira Corporation Information
- 11.15.2 Tekmira Description and Business Overview
- 11.15.3 Tekmira Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Tekmira Products Offered
- 11.15.5 Tekmira Related Developments
- 11.16 Alnylam Pharmaceuticals
- 11.16.1 Alnylam Pharmaceuticals Corporation Information
- 11.16.2 Alnylam Pharmaceuticals Description and Business Overview
- 11.16.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Alnylam Pharmaceuticals Products Offered
- 11.16.5 Alnylam Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 RNA Drugs Market Estimates and Projections by Region
- 12.1.1 Global RNA Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global RNA Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America RNA Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: RNA Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: RNA Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: RNA Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe RNA Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: RNA Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: RNA Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: RNA Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific RNA Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: RNA Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: RNA Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: RNA Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America RNA Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: RNA Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: RNA Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: RNA Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa RNA Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: RNA Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: RNA Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: RNA Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key RNA Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 RNA Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on RNA Drugs . Industry analysis & Market Report on RNA Drugs is a syndicated market report, published as Global (United States, European Union and China) RNA Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of RNA Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
